First Line Therapy - is Imatinib still the Best Frontline Treatment?
This discussion is a recording of the iCMLf Regional Discussion on CML for South Asia held on 3 June 2026
Regional Experts:
Dr Mehreen Ali Khan
Armed Forces Bone Marrow
Transplant Centre
Rawalpindi, Pakistan
Professor Hemant Malhotra
Sri Ram Cancer and Super-speciality Center
Mahatma Gandhi Medical College Hospital
Jaipur, India
International Experts:
Professor Gianantonio Rosti
IRCCS/SIRHHC Scientific Institute for Research, Hospitalisation and Health Care
Meldola (FC), Italy
Professor Susanne Saussele
CML Excellence Center
Hematology and Oncology
University of Mannheim,
Mannheim, Germany
See all our 2026 South Asia Regional Discussion Groups on YouTube
Find all our South Asia Regional Discussion Groups on YouTube
00:00 Welcome and Introductions
04:59 Yes! Imatinib Remains the Best Frontline Treatment
22:34 No! There are Better Choices than Imatinib for Frontline Treatment
46:45 Rebuttals, Questions and Comments
01:26:26 Closing Comments